These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4521070)

  • 1. Evaluation of the effects of 5,7-dihydroxytryptamine on serotonin and catecholamine neurons in the rat CNS.
    Baumgarten HG; Björklund A; Lachenmayer L; Nobin A
    Acta Physiol Scand Suppl; 1973; 391():1-19. PubMed ID: 4521070
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-lasting selective depletion of brain serotonin by 5,6-dihydroxytryptamine.
    Baumgarten HG; Björklund A; Lachenmayer L; Nobin A; Stenevi U
    Acta Physiol Scand Suppl; 1971; 373():1-15. PubMed ID: 5291907
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of 5,6-dihydroxytryptamine on monoaminergic neurones in the central nervous system of the rat.
    Baumgarten HG; Evetts KD; Holman RB; Iversen LL; Vogt M; Wilson G
    J Neurochem; 1972 Jun; 19(6):1587-97. PubMed ID: 4402486
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurotoxicity of hydroxylated tryptamines: structure-activity relationships. 1. Long-term effects on monoamine content and fluorescence morphology of central monoamine neurons.
    Baumgarten HG; Björklund A; Nobin A; Rosengren E; Schlossberger HG
    Acta Physiol Scand Suppl; 1975; 429():5-27. PubMed ID: 1064287
    [No Abstract]   [Full Text] [Related]  

  • 5. Axonal degeneration and regeneration of bulbo-spinal indolamine neurons after 5,6-dihydroxytryptamine treatment.
    Nobin A; Baumgarten HG; Björklund A; Lachenmayer L; Stenevi U
    Brain Res; 1973 Jun; 56():1-24. PubMed ID: 4715620
    [No Abstract]   [Full Text] [Related]  

  • 6. Regeneration of central serotonin neurons after axonal degeneration induced by 5,6-dihydroxytryptamine.
    Björklund A; Nobin A; Stenevi U
    Brain Res; 1973 Feb; 50(1):214-20. PubMed ID: 4690548
    [No Abstract]   [Full Text] [Related]  

  • 7. 5,7-Dihydroxytryptamine: improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine.
    Björklund A; Baumgarten HG; Rensch A
    J Neurochem; 1975 Apr; 24(4):833-5. PubMed ID: 1123645
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term recovery of serotonin concentrations in the rat CNS following 5,6-dihydroxytryptamine.
    Baumgarten HG; Lachenmayer L; Björklund A; Nobin A; Rosengren E
    Life Sci I; 1973 Apr; 12(8):357-64. PubMed ID: 4696889
    [No Abstract]   [Full Text] [Related]  

  • 9. On the behavioral and neurochemical actions of 6-hydroxydopa and 5,6-dihydroxytryptamine in rats.
    Richardson JS; Cowan N; Hartman R; Jacobowitz DM
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):29-44. PubMed ID: 4847904
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical effects of dihydroxylated tryptamines on central indoleamine neurones.
    Gerson S; Baldessarini RJ; Wheeler SC
    Neuropharmacology; 1974 Nov; 13(10-11):987-1004. PubMed ID: 4280023
    [No Abstract]   [Full Text] [Related]  

  • 11. Ventrolateral lesions at the ponto-medullary junction and the effects of noradrenaline on respiratory rhythm in rat brainstem-spinal cord preparations.
    Ito Y; Saiki C; Makino M; Matsumoto S
    Life Sci; 2009 Aug; 85(7-8):322-6. PubMed ID: 19567253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-specific actions of dihydroxylated tryptamines in the central nervous system of the rat.
    Gerson S; Baldessarini RJ
    J Pharm Pharmacol; 1974 Jan; 26(1):71-3. PubMed ID: 4150942
    [No Abstract]   [Full Text] [Related]  

  • 13. Facilitation of respiratory rhythm by a mu-opioid agonist in newborn rat pons-medulla-spinal cord preparations.
    Tanabe A; Fujii T; Onimaru H
    Neurosci Lett; 2005 Feb; 375(1):19-22. PubMed ID: 15664115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 5,6-dihydroxytryptamine on nerve terminal serotonin and serotonin uptake in the rat brain.
    Björklund A; Nobin A; Stenevi U
    Brain Res; 1973 Apr; 53(1):117-27. PubMed ID: 4697240
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemical lesioning of central monoamine axons by means of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine.
    Björklund A; Baumgarten HG; Nobin A
    Adv Biochem Psychopharmacol; 1974; 10():13-33. PubMed ID: 4846535
    [No Abstract]   [Full Text] [Related]  

  • 16. The inhibition of (3H) biogenic amine accumulation into rat brain tissue slices by various tryptamine derivatives.
    Heikkila RE; Cohen G
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):539-47. PubMed ID: 4824828
    [No Abstract]   [Full Text] [Related]  

  • 17. Intraventricular administration of vasopressin and oxytocin effects the steady-state levels of serotonin, dopamine and norepinephrine in rat brain.
    Schwarzberg H; Kovács GL; Szabó G; Telegdy G
    Endocrinol Exp; 1981; 15(2):75-80. PubMed ID: 6973462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogeny of monoamine neurons in the locus coeruleus, Raphe nuclei and substantia nigra of the rat. I. Cell differentiation.
    Lauder JM; Bloom FE
    J Comp Neurol; 1974 Jun; 155(4):469-81. PubMed ID: 4847734
    [No Abstract]   [Full Text] [Related]  

  • 19. Analgetic contribution of sufentanil during halothane anesthesia: a mechanism involving serotonin.
    Althaus JS; Miller ED; Moscicki JC; Hecker BR; DiFazio CA
    Anesth Analg; 1985 Sep; 64(9):857-63. PubMed ID: 3161420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further mapping of central 5-hydroxytryptamine neurons: studies with the neurotoxic dihydroxytryptamines.
    Fuxe K; Jonsson G
    Adv Biochem Psychopharmacol; 1974; 10():1-12. PubMed ID: 4846539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.